Cardiogenic Shock: A State-of-the-Art Review

Aaron Samuels1, Tetiana Zolotarova2, Mark J Eisenberg3

  • 1Department of Medicine, McGill University, Montreal, Canada.

PubMed

Insights

Cardiogenic shock care has evolved, with survival improving due to new treatments and standardized classifications. The focus is now on long-term recovery for patients experiencing this critical cardiovascular emergency.

Area of Science:

  • Cardiovascular Medicine
  • Critical Care Medicine

Background:

  • Cardiogenic shock, a severe cardiac dysfunction causing inadequate tissue perfusion, is a critical cardiovascular emergency.
  • The etiology of cardiogenic shock has shifted from predominantly ischemic to non-ischemic causes like heart failure over the last two decades.
  • Evolving classification systems (SCAI stages, SHOCK-ARCF) aid in standardized diagnosis and risk stratification.

Purpose of the Study:

  • To review the evolving landscape of cardiogenic shock management.
  • To highlight advancements in diagnosis, risk stratification, and therapeutic strategies.
  • To discuss the shift in focus towards long-term survivorship.

Main Methods:

  • Review of modern classification systems for diagnosis and risk stratification.
  • Analysis of traditional and contemporary management strategies, including pharmacotherapy, revascularization, and mechanical circulatory support.
  • Examination of system-level improvements like multidisciplinary shock teams and CICU liberation bundles.

Main Results:

  • Standardized classification systems have improved diagnosis and risk stratification.
  • Advances in management, including mechanical support and team-based care, have led to decreased in-hospital mortality.
  • Early outcomes have improved, prompting a shift towards survivorship.

Conclusions:

  • Modern management strategies and system-level improvements have significantly reduced in-hospital mortality for cardiogenic shock.
  • The focus of care is transitioning from acute management to addressing the long-term physical, cognitive, and psychological needs of survivors.
  • Ensuring meaningful, independent living is the new goal for cardiogenic shock survivorship.

Related Concept Videos

Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
937
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
622
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
395
Blood Pressure Imbalances and Circulatory Shock01:24

Blood Pressure Imbalances and Circulatory Shock

Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
1.7K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
493
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
540